Vaccine Delivery Devices Market

Vaccine Delivery Devices Market Distribution by Type of Device (Needle Free Injection Systems, Oral Delivery Systems, Nasal Delivery Systems, Jet Injectors, Microneedle Patches and Microinjectors), Route of Administration (Oral, Intramuscular, Intranasal, Intradermal and Subcutaneous), Type of Vaccine and Key Geographical Regions: Industry Trends and Global Forecasts, 2019-2030

  • Lowest Price Guaranteed From USD 4,499

  • Companies Covered
    404

  • Pages
    528

  • View Count
    17400

Vaccine Delivery Devices Market Overview

[COVID-19 SERIES] The vaccine delivery devices market is estimated to be worth $1.5 billion by 2030, driven by the increase in global vaccination coverage.  According to experts, the global vaccines market is anticipated to generate revenues worth USD 100 billion by 2025. Data presented by the WHO indicates that the current global vaccination coverage is nearly 85%; this is believed to be responsible for preventing close to three million deaths from diseases, such as diphtheria, tetanus, whooping cough and measles. Recent global immunization records indicate that more than 115 million children were immunized against diphtheria, tetanus and pertussis in 2018. Given the rate at which the global population is growing, the demand for vaccines is likely to increase significantly. However, biopharmaceutical developers are plagued by concerns related to storage and handling of such preventive / therapeutic products. One commonly reported issue is related to vaccine administration. Despite the success of conventional delivery approaches, which rely on the intramuscular and subcutaneous routes of administration, the present scenario dictates that further improvements are required in order to deal with challenges related to large scale immunization initiatives. Some of the commonly reported disadvantages of the conventional (parenteral) mode of delivery include pain during administration, risk of cross contamination, needlestick injuries, and inaccurate dosing. 

This image highlights the context of Vaccine Delivery Devices Market report. Owing to a variety of relevant reasons, which include trypanophobia and dependence on the cold chain, there is an evident  demand for innovative and user-friendly vaccine delivery systems that are also safe and efficient This image provides list of Novel Vaccine Delivery Devices. Over 130 novel delivery devices, including marketed / under development products, are being investigated for the delivery of both liquid and solid formulations of vaccines This image presents current market landscape of Novel Vaccine Delivery Devices Market. The market landscape is fragmented, featuring both new entrants (small companies) and established players (mid-large sized enterprises); the US is currently considered to be the hub for vaccine delivery focused firms

Of late, there has been an evident shift in interest to non-invasive immunization methods, which include oral, intranasal and transdermal modes of administration. Currently, many biopharmaceutical companies and clinical research institutes are engaged in the development of novel vaccine drug delivery system, taking into consideration the specific requirements of large scale immunization initiatives. As a result, significant efforts have been put into the development of drug delivery technologies / devices, such as microneedle patches, electroporation-based needle free vaccine injection systems, jet injectors, inhalation-based delivery systems, biodegradable implants and certain novel types of oral delivery systems. It is worth highlighting that most of the aforementioned systems are specifically being designed to facilitate pain-free administration of vaccines and allow self-administration. Additionally, these novel vaccine delivery devices can play an important role in vaccination during the event  of disease outbreaks / pandemics (such as the one being faced due to the novel coronavirus / COVID-19), where medical centers may not be equipped to deal with large scale immunization campaigns. Vaccine developers are also attempting to devise ways to make such products more stable so as to eliminate the need for cold chain in transporting such products. Given the pace of innovation in this field, it is anticipated that the novel vaccine delivery devices market is likely to witness a considerable market growth during the forecast period. 

Key Companies in Vaccine Delivery Devices Market

Examples of key companies engaged in vaccine delivery devices market (which have also been profiled in this market report; the complete list of companies is available in the full report) include 3M, Becton Dickinson, Consort Medical, D'Antonio Consultants International, Enesi Pharma, Ichor Medical Systems, Iconovo, Inovio Pharmaceuticals, PharmaJet and Union Medico. This market report includes an easily searchable excel database of all the companies providing vaccine delivery devices, worldwide.

Recent Developments in Vaccine Delivery Devices Market:

Several recent developments have taken place in the field of vaccine delivery devices market. We have outlined some of these recent initiatives below. These developments, even if they took place post the release of our market report, substantiate the overall market trends that have been outlined in our analysis.

  • In September 2023, SK biosciences entered into a joint development agreement with Vaxxas with an aim to develop needle-free patch delivery of typhoid vaccine. 
  • In January 2023, MTD Group received the FDA clearance for DropSafe Sicura passive safety needle, an injection needle with a fully passive mechanism, which is used for the intramuscular and subcutaneous injection of vaccines and other drugs.

Scope of the Report

The “Novel Vaccine Delivery Devices Market, 2019-2030” market report features an extensive study of the current market landscape, market size, market share, market growth, market trends, market value, market forecast, market outlook, statistics and future opportunities of the vaccine delivery devices market.

This image highlights market trends of Novel Vaccine Delivery Devices Market. A myriad of invasive and non-invasive delivery devices based on different routes of administration are under evaluation; majority of them are in clinical stages of development This image highlights competitive analysis of Novel Vaccine Delivery Devices. In order to achieve an edge over competing players, delivery device developers in this market are increasingly focusing on the integration of advanced features in their respective products / offerings This image provides list of Likely Drug Candidates for Delivery via Novel Vaccine Delivery Devices. An evaluation of 490+ marketed and pipeline products revealed that several vaccine candidates are likely to be considered for delivery via novel vaccine delivery devices in the near future

Amongst other elements, the market research report includes:

  • A detailed assessment of the overall novel vaccine delivery devices market landscape, featuring an elaborate list of device developers and analysis based on a number of relevant parameters, such as year of establishment, company size, geographical location, type of device (autoinjectors, microneedle patches, jet injectors, dry powder inhalers, microinjectors, nasal delivery systems, pen injectors, biodegradable implants, electroporation-based needle free vaccine injection systems and novel oral delivery systems), route of administration (subcutaneous, transdermal, intramuscular, intradermal, inhalation, intranasal, and oral), drug delivery mechanism (mechanical, electrical and miscellaneous), nature of vaccine administration (invasive and non-invasive), speed of administration (fast, moderate and slow), self- administration potential, provisions for audio / visual feedback, device usability (disposable and reusable), type of needle (needleless, fixed needle, detachable needle, and hidden needle), and current development status of novel vaccine drug delivery system (preclinical / discovery, clinical and marketed).
  • A detailed competitiveness analysis of novel vaccine delivery devices, taking into consideration the supplier power (based on the year of establishment of developer company) and key product specifications (such as route of administration, device usability, drug delivery mechanism, availability of needle safety system, speed of administration, self-administration potential, provisions for audio / visual feedback, nature of administration, cold chain requirement and current status of development).
  • An analysis evaluating the effectiveness of various vaccines delivery devices in order to compare their respective strengths and capabilities based on a variety of relevant parameters, such as type of active ingredient, dosage form, route of administration, target disease indication and target patient population.
  • A detailed list of marketed and pipeline vaccine candidates that are anticipated to be developed in combination with novel vaccine delivery devices in the near future, featuring analysis based on parameters, such as type of active ingredient, dosage form, route of administration, target disease indication and target patient population. 
  • Elaborate profiles of prominent product developers engaged in vaccine delivery devices market; each profile features a brief overview of the company, its financial information (if available), information on its product portfolio, recent developments and an informed future outlook.
  • An analysis of recent collaborations and partnership agreements inked in vaccine delivery devices market since 2014, including details of deals that were / are focused on novel vaccine delivery devices. The partnerships captured in the report were analyzed on the basis of year of establishment, type of agreement, type of device, type of vaccine, type of active ingredient and target disease indication.
  • A discussion on important, industry-specific trends, key market drivers and challenges, under a comprehensive SWOT framework, featuring a qualitative Harvey ball analysis that highlights the relative impact of each SWOT parameter on the overall market.

The key objective of vaccine delivery devices market report is to provide a detailed market analysis in order to estimate the existing market size, market share, market growth, market trends, market value, market forecast, market outlook, statistics and future opportunity for vaccine delivery devices market during the forecast period. Based on various parameters, such as number of marketed / pipeline products, price of devices (for commercially available products only) and estimated annual adoption rate, we have developed an informed estimate on the likely evolution of the market over the forecast period 2019-2030. In addition, we have provided the likely distribution of the current and forecasted opportunities across [A] type of device (electroporation-based needle free vaccine injection systems, oral delivery systems, nasal delivery systems, jet injectors, microneedle patches and microinjectors), [B] route of administration (oral, intramuscular, intranasal, intradermal and subcutaneous), [C] type of vaccine (Bivalent Oral Polio Vaccine, BCG Vaccine, DTP-HepB-Hib Vaccine, Pneumococcal Conjugate Vaccine, Influenza Vaccine, Measles Vaccine, Tetanus-Diphtheria Vaccine and Others) and [D] key geographical regions (North America, Europe, Asia and rest of the world). In order to account for future uncertainties and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry’s growth.

This image highlights the partnership activity undertaken by players engaged in Novel Vaccine Delivery Devices Market. The increasing interest in this field is also reflected in the partnership activity; deals inked in the recent past were focused on a diverse range of devices, and involved both international and indigenous stakeholders This image describes Impact of Key Market Drivers and Constraints. The benefits of the novel vaccine delivery systems presently outweigh the challenges related to their development and sales; the growing optimism in this domain is evident in the opinions of industry veterans This image provides information on the current and future market trends and potential growth of Novel Vaccine Delivery Devices Market. The future opportunity for novel vaccine delivery devices is expected to be distributed across various product types, routes of administration and key geographical regions

The opinions and insights presented in the market report were influenced by discussions held with senior stakeholders in vaccine delivery devices market. The market research report features detailed transcripts of interviews held with the following industry stakeholders:

  • Michael Schrader, Chief Executive Officer and Founder, Vaxess Technologies
  • Mikael Ekstrom and Roger Lassing, Vice President, Business Development, Iconovo
  • Henry King, Market Intelligence and Business Development Manager, Innoture

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this market research report are in USD, unless otherwise specified.

Frequently Asked Questions

Question 1: What are vaccine delivery devices?

Answer: Vaccine delivery devices belong to a specific class of drug delivery devices used for the convenient administration of vaccines and other biologics.

Question 2: How big is the vaccine delivery devices market?

Answer: The vaccine delivery devices market size is estimated to be worth $1.5 billion in 2030.

Question 3: Who are the leading companies in the vaccine delivery devices market?

Answer: Examples of key companies engaged in vaccine delivery devices market (which have also been profiled in this market report; the complete list of companies is available in the full report) include 3M, Becton Dickinson, Consort Medical, D'Antonio Consultants International, Enesi Pharma, Ichor Medical Systems, Iconovo, Inovio Pharmaceuticals, PharmaJet and Union Medico.

Question 4: How many companies are currently engaged in the vaccine delivery devices market?

Answer: Presently, over 75 companies are engaged in the vaccine delivery devices market, offering novel and innovative devices for vaccine administration.

Question 5: How many devices are marketed / under development by the companies engaged in the vaccine delivery devices market?

Answer: Over 130 unique devices are marketed / under development for vaccine delivery.

Question 6: How many vaccine candidates are expected to be evaluated using the novel devices?

Answer: Close to 500 vaccine candidates are expected to be evaluated using the novel devices developed by companies engaged in the vaccine delivery devices market.

PRICING DETAILS

This license grants the right of use of the purchased report to a single recipient only (normally the person who buys the report). You may access the material on your computer, as and when required, for your own personal use. You may also print Read more about Single-User License

This license grants the right of use of the purchased report by the employees of a business unit at a particular site/office location. The report may be accessed on the computer of any employee within the business unit. You may also print multiple Read more about One Location Site License

This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm/enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the Read more about Enterprise License

Discounts available for multiple report purchases
Click here to send an email to Roots Analysis team. sales@rootsanalysis.com